Literature DB >> 34270905

Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the ADRB1 Arg389Arg Genotype.

Jonathan P Piccini1, Christopher Dufton2, Ian A Carroll2, Jeff S Healey3, William T Abraham4, Yaariv Khaykin5, Ryan Aleong6, Steven K Krueger7, William H Sauer8, Stephen B Wilton9, Michiel Rienstra10, Dirk J van Veldhuisen10, Inder S Anand11, Michel White12, A John Camm13, Paul D Ziegler14, Debra Marshall2, Michael R Bristow2,6, Stuart J Connolly3.   

Abstract

[Figure: see text].

Entities:  

Keywords:  atrial fibrillation; atrial flutter; bucindolol; heart failure; metoprolol

Mesh：

Substances：

Year:  2021        PMID： 34270905     DOI： 10.1161/CIRCEP.120.009591

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN： 1941-3084


  2 in total

1.  Premarket assessment of molecular alterations in drug targets: a case study of 2020 drug approvals.

Authors:  Oluseyi Adeniyi; Mary Hwang; Jielin Sun; Robert N Schuck
Journal:  Pharmacogenomics       Date:  2022-04-20       Impact factor: 2.638

2.  Dose-limiting, adverse event-associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial.

Authors:  William T Abraham; Jonathan P Piccini; Christopher Dufton; Ian A Carroll; Jeffrey S Healey; Christopher M O'Connor; Debra Marshall; Ryan Aleong; Dirk J van Veldhuisen; Michiel Rienstra; Stephen B Wilton; Michel White; William H Sauer; Inder S Anand; Sophia P Huebler; Stuart J Connolly; Michael R Bristow
Journal:  Heart Rhythm O2       Date:  2021-11-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.